Tonghua Golden-Horse Pharmaceutical Industry Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tonghua Golden-Horse Pharmaceutical Industry Co Ltd with three other
companies in this sector in CHINA :
Harbin Medisan Pharmaceutical Co Ltd
sales of 2.10 billion Chinese Renmimbi [US$319.85 million]
of which 94%
Shanghai Shenqi Pharmaceutical Investment Management CoLtd
(1.93 billion Chinese Renmimbi [US$293.30 million]
of which 75%
was Pharmaceutical Manufacturing), and
Chongqing Lummy Pharmaceutical Co Ltd
(1.86 billion Chinese Renmimbi [US$282.87 million]
of which 91%
was Chemical Manufacturing).
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd reported sales of 1.98 billion Chinese Renmimbi (US$300.85 million)
December of 2019.
decrease of 5.6%
versus 2018, when the company's sales were 2.09 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 86.7% decline
in Others, from 19.06 million Chinese Renmimbi to 2.53 million Chinese Renmimbi.
There were also decreases in sales in
Chemical Medicine (down 11.3% to 1.21 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Proprietary Chinese Medicine. (up 7.1% to 762.45 million Chinese Renmimbi)
Active Pharmaceutical Ingredients (up 36.7% to 6.87 million Chinese Renmimbi)